Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BrightView (BV) downgraded to Hold from Buy at Stifel with analyst Shlomo Rosenbaum saying he points to the company's "erratic performance" over the past year, its "inherent lack of visibility" due to weather related items, and its free cash flow uncertainty due to the Development segment's subprime contractor position. 2. Dollar Tree (DLTR) downgraded to Market Perform from Outperform at Telsey Advisory with analyst Matthew Boss saying the company's Q3 miss and Q4 guidance cut takes it multi-year growth algorithm off the table. 3. Axon (AAXN) downgraded to Market Perform from Strong Buy at Raymond James with analyst Brian Gesuale saying he believes the stock's "unsustainable energetic move higher" this month cannot be reconciled with fundamentals of the business. 4. PVH Corp. (PVH) downgraded to In Line from Outperform at Evercore ISI. 5. Neon Therapeutics (NTGN) downgraded to Neutral from Buy at H.C. Wainwright with analyst Raghuram Selvaraju saying Neon announced it will be reducing its workforce by approximately 24% and will cease funding additional research and development for its cancer vaccine programs, NEO-PV-01 and NEO-SV-01. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.